RecruitingNot ApplicableNCT07778173

Three-Dimensional Molds Based on Radiological imagEs in Patients With Cancer: the DIRECT Trial


Sponsor

Tampere University Hospital

Enrollment

30 participants

Start Date

May 31, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Determination of the sites from which the histopathological samples in surgically removed lesions are collected is still done by eye by a pathologist. As radiological determination of regions of interest has already proven useful in in vivo use cases, the implementation of sampling of ex vivo lesions with the help of radiological imaging suggests great potential. By developing and implementing mold printing processes, these molds have the potential to vastly improve the accuracy and consistency of histopathological sampling and collection of tissue samples from different regions of tumor, leading to improved characterization, more individualized treatments, and eventually better survival.


Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called 3D-printed tumor mold for tissue sampling for people with cancer and tumor. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURE3D-printed tumor mold for tissue sampling

3D-printed tumor mold for tissue sampling


Locations(1)

Tampere University Hospital

Tampere, Finland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07778173


Related Trials